Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Maeva Y. I. Chauvin, Ph.D.

Concepts (81)

Back to Profile
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Maeva Chauvin's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Maeva Chauvin has written about over time.
Xenograft Model Antitumor Assays, 2 publications between 2017 and 2021, average publication date May 2019. Cell Survival, 3 publications between 2017 and 2021, average publication date December 2019. Receptors, Peptide, 4 publications between 2017 and 2022, average publication date August 2020. Ovarian Neoplasms, 4 publications between 2017 and 2023, average publication date November 2020. Caspase 3, 1 publications between 2021 and 2021, average publication date January 2021. Receptors, Transforming Growth Factor beta, 5 publications between 2017 and 2023, average publication date March 2021. Phosphorylation, 2 publications between 2021 and 2021, average publication date March 2021. Activin Receptors, Type I, 1 publications between 2021 and 2021, average publication date May 2021. Antibodies, Bispecific, 1 publications between 2021 and 2021, average publication date May 2021. Bone Morphogenetic Protein Receptors, Type I, 1 publications between 2021 and 2021, average publication date May 2021. Smad1 Protein, 1 publications between 2021 and 2021, average publication date May 2021. Smad5 Protein, 1 publications between 2021 and 2021, average publication date May 2021. Pregnancy Complications, Infectious, 2 publications between 2020 and 2021, average publication date May 2021. Ovary, 3 publications between 2021 and 2022, average publication date September 2021. Ovarian Follicle, 3 publications between 2021 and 2022, average publication date February 2022. Anti-Mullerian Hormone, 5 publications between 2021 and 2023, average publication date February 2022. Contraceptive Agents, 1 publications between 2022 and 2022, average publication date April 2022. Drug Repositioning, 1 publications between 2022 and 2022, average publication date April 2022. Ovulation, 1 publications between 2022 and 2022, average publication date October 2022. Peptide Hormones, 2 publications between 2023 and 2023, average publication date June 2023.

To see the data from this visualization as text, click here.
Chauvin's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (81)
Explore
_
Co-Authors (21)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.